Acturis launches AI Predict

data strategy for AI

Acturis has launched AI Predict to bring the power of artificial intelligence and machine learning into its software-as-a-service platform.

According to the technology provider, brokers will benefit in a practical and seamless way, making the adoption and impact of AI simple to realise for every broker.

Acturis AI Predict has launched with two different AI models, Product Cross Sell and Propensity to Renew, both designed to aid in winning and retaining businesses.

Product Cross Sell suggestions will help to drive organic growth across the client base, and Propensity to Renew will focus the efforts of renewal teams to where it is

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

Register

Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

This address will be used to create your account

Interview: Addept Group managing director Richard Finan

Addept MD Richard Finan gives Insurance Age the lowdown on his return to the market; his thoughts on changes to the MGA market in the wake of Consumer Duty; and the challenges of creating ancillary products in a post-FCA GAP intervention world.

QBE unveils QCyberProtect

QBE Insurance has launched QCyberProtect, describing it as a comprehensive and globally consistent cyber policy designed to enhance cyber resilience for a range of clients worldwide.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: